Monday, January 13, 2020 11:33:31 PM
"With respect to the current status of the convertible notes within the Company, the original principal amounts of the notes to the Company, earlier this year, was approximately $1.75M. As of today, the principal balances remaining are approximately $890K. Not all remaining notes are due and payable or eligible for conversion at this time. The largest noteholder was fully converted earlier this week and the Company has $0 remaining with this noteholder. Whilst the Company was able to curtail the conversions of some of the smaller noteholders earlier this month, several smaller noteholders were able to complete conversions this week. The Company is in discussions with the majority of the remaining holders to settle the remaining balances from future revenues and private equity sources."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM